Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome

European Respiratory Journal

Volumn 31, Issue 5, 2008, Pages 1046-1053

  Faure, P ^a,b   Tamisier, R ^a,b   Baguet, J P ^a   Favier, A ^a   Halimi, S ^a   Levy P ^a,b   Pepin J L ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b University Grenoble Alpes   (France)

Author keywords

Albumin; Antioxidant properties; Obstructive sleep apnoea; Oxidative stress; Protein glycation; Thiols

Indexed keywords

ACRYLAMIDE; FRUCTOSAMINE; SERUM ALBUMIN; THIOL DERIVATIVE; ANTIOXIDANT; ISOPROSTANE DERIVATIVE; ISOPROSTANE F2ALPHA III;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; FRUCTOSAMINE BLOOD LEVEL; GLYCATION; HUMAN; METABOLIC PARAMETERS; OXIDATION; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SLEEP PARAMETERS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; GLYCOSYLATION; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; URINE;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FRUCTOSAMINE; GLYCOSYLATION; HUMANS; ISOPROSTANES; MIDDLE AGED; OXIDATION-REDUCTION; SERUM ALBUMIN; SLEEP APNEA, OBSTRUCTIVE; SULFHYDRYL COMPOUNDS;

EID: 44449138990     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00062707     Document Type: Article

References (30)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
2. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206-1214.
3. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
4. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
5. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27: 123-128.
6. Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000; 16: 644-647.
7. Svatikova A, Wolk R, Lerman LO, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J 2005; 26: 2435-2439.
8. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94: 179-184.
9. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-570.
10. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004; 28: 87-91.
11. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003; 136: 167-178.
12. Barceló A, Barbé F, de la Peña M, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006; 27: 756-760.
13. Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001; 3: 293-311.
14. Faure P, Troncy L, Lecomte M, et al. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab 2005; 31: 169-177.
15. Rondeau P, Armenta S, Caillens H, Chesne S, Bourdon E. Assessment of temperature effects on b-aggregation of native and glycated albumin by FTIR spectroscopy and PAGE: relations between structural changes and antioxidant properties. Arch Biochem Biophys 2007; 460: 141-150.
16. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
17. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999; 13: 233-244.
18. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211-1219.
19. Bourdon E, Loreau N, Lagrost L, Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic Res 2005; 39: 15-20.
20. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003; 4: 225-228.
21. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-823.
22. Cohen MP, Clements RS, Cohen JA, Shearman CW. Glycated albumin promotes a generalized vasculopathy in the db/db mouse. Biochem Biophys Res Commun 1996; 218: 72-75.
23. Schram MT, Schalkwijk CG, Bootsma AH, et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 2005; 46: 232-237.
24. Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999; 48: 2446-2453.
25. Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 2002; 39: 22-28.
26. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-353.
27. Tan KC, Chow WS, Lam JC, et al. Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep 2006; 29: 329-333.
28. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667.
29. Ryan S, McNicholas WT, Taylor CT. A critical role for p38 MAP kinase in NF-κB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun 2007; 355: 728-733.
30. Cantin AM, Paquette B, Richter M, Larivée P. Albumin-mediated regulation of cellular glutathione and nuclear factor κB activation. Am J Respir Crit Care Med 2000; 162: 1539-1546.